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Background
While it is relatively easy to elicit antigen-specific serum
antibody it is much more difficult to establish meaning-
ful levels of specific antibody at mucosal surfaces, the
major route of viral invasion. We sought to determine if
mucosal vaccination using topical vaginal application
could initiate local antigen-specific immunity, enhance
previously existing systemic immunity or re-target
responses to the mucosae.
Methods
We used a silicone elastomer ring device to deliver a pro-
tein vaccine formulation to the vaginal mucosal surface.
Cylindrical rod-shaped inserts (2 x 7mm) were prepared
by freeze-drying an aqueous hydroxypropylmethylcellu-
lose (HPMC) gel containing recombinant CN54gp140
(500μg) with and without the TLR7/8 agonist R848 (resi-
quimod – 500μg). Inserts were loaded into cavities within
each ring such that only the ends of the inserts were
exposed. Sheep received an intramuscular injection of
100μg HIVgp140 + 200μg R848 followed by three succes-
sive ring applications of one week duration, separated by
one month intervals. Other sheep received only the ring
devices without priming. Serum and vaginal mucosal
fluids were sampled every two weeks and analysed by
CN54gp140 ELISA. Antigen-specific cellular responses
were determined at necropsy.
Results
Vaccine antigen-specific serum antibody responses were
detected in both the intramuscularly primed and vaginal
mucosally-primed groups. Those animals that received
only vaginal vaccinations had identical IgG but superior
IgA responses. Analysis revealed that all animals exhib-
ited mucosal antigen-specific IgG and IgA with the IgA
responses 30-fold greater than systemic levels. Surpris-
ingly, very high numbers of antigen-specific B cells were
detected in local genital draining lymph nodes.
Conclusion
We have elicited local genital cellular and humoral
immune responses after topical application of an adju-
vanted antigen formulation within a novel vaginal ring
vaccine delivery device. This regimen and delivery
method elicited high levels of antigen-specific mucosal
IgA and large numbers of local antigen-reactive B cells,
both likely essential for effective mucosal protection.
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